Literature DB >> 21292747

Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages.

Travis McQuiston1, Chiara Luberto1, Maurizio Del Poeta2,1,3,4.   

Abstract

The pathogenic fungus Cryptococcus neoformans is a major cause of morbidity and mortality in immunocompromised individuals. Infection of the human host occurs through inhalation of infectious propagules following environmental exposure. In the lung, C. neoformans can reside in the extracellular environment of the alveolar spaces or, upon phagocytosis, it can survive and grow intracellularly within alveolar macrophages (AMs). In previous studies, we found that sphingosine kinase 1 (SK1) influenced the intracellular residency of C. neoformans within AMs. Therefore, with this study we aimed to examine the role of the SK1 lipid product, sphingosine-1-phosphate (S1P), in the AMs-C. neoformans interaction. It was found that extracellular S1P enhances the phagocytosis of C. neoformans by AMs. Using both genetic and pharmacological approaches we further show that extracellular S1P exerts its effect on the phagocytosis of C. neoformans by AMs through S1P receptor 2 (S1P2). Interestingly, loss of S1P2 caused a dramatic decrease in the mRNA levels of Fcγ receptors I (FcγRI), -II and -III. In conclusion, our data suggest that extracellular S1P increases antibody-mediated phagocytosis through S1P2 by regulating the expression of the phagocytic Fcγ receptors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292747      PMCID: PMC3140583          DOI: 10.1099/mic.0.045989-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  74 in total

1.  Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma.

Authors:  A J Ammit; A T Hastie; L C Edsall; R K Hoffman; Y Amrani; V P Krymskaya; S A Kane; S P Peters; R B Penn; S Spiegel; R A Panettieri
Journal:  FASEB J       Date:  2001-05       Impact factor: 5.191

2.  Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide.

Authors:  D L Goldman; S C Lee; A J Mednick; L Montella; A Casadevall
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway.

Authors:  Lily I Jiang; Julie Collins; Richard Davis; Keng-Mean Lin; Dianne DeCamp; Tamara Roach; Robert Hsueh; Robert A Rebres; Elliott M Ross; Ronald Taussig; Iain Fraser; Paul C Sternweis
Journal:  J Biol Chem       Date:  2007-02-05       Impact factor: 5.157

Review 4.  Mechanisms of mycobacterial persistence in tuberculosis.

Authors:  David J Kusner
Journal:  Clin Immunol       Date:  2005-03       Impact factor: 3.969

5.  Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3.

Authors:  Scott Shapiro; David O Beenhouwer; Marta Feldmesser; Carlos Taborda; Michael C Carroll; Arturo Casadevall; Matthew D Scharff
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

6.  Natural lysophospholipids reduce Mycobacterium tuberculosis-induced cytotoxicity and induce anti-mycobacterial activity by a phagolysosome maturation-dependent mechanism in A549 type II alveolar epithelial cells.

Authors:  Emanuela Greco; Marilina B Santucci; Michela Sali; Francesca R De Angelis; Massimiliano Papi; Marco De Spirito; Giovanni Delogu; Vittorio Colizzi; Maurizio Fraziano
Journal:  Immunology       Date:  2009-06-22       Impact factor: 7.397

7.  Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast.

Authors:  T R Kozel; G S Pfrommer
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

8.  Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages.

Authors:  Gary M Cox; Thomas S Harrison; Henry C McDade; Carlos P Taborda; Garrett Heinrich; Arturo Casadevall; John R Perfect
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival.

Authors:  Oscar Zaragoza; Cara J Chrisman; Maria Victoria Castelli; Susana Frases; Manuel Cuenca-Estrella; Juan Luis Rodríguez-Tudela; Arturo Casadevall
Journal:  Cell Microbiol       Date:  2008-06-28       Impact factor: 3.715

10.  Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans.

Authors:  Chiara Luberto; Beatriz Martinez-Mariño; Daniel Taraskiewicz; Benjamin Bolaños; Pasquale Chitano; Dena L Toffaletti; Gary M Cox; John R Perfect; Yusuf A Hannun; Edward Balish; Maurizio Del Poeta
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

View more
  25 in total

1.  Methamphetamine Impairs IgG1-Mediated Phagocytosis and Killing of Cryptococcus neoformans by J774.16 Macrophage- and NR-9640 Microglia-Like Cells.

Authors:  Lilit Aslanyan; Hiu H Lee; Vaibhav V Ekhar; Raddy L Ramos; Luis R Martinez
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

Review 2.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 3.  An update on the biology of sphingosine 1-phosphate receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  J Lipid Res       Date:  2014-01-23       Impact factor: 5.922

4.  FTY720 Attenuates Infection-Induced Enhancement of Aβ Accumulation in APP/PS1 Mice by Modulating Astrocytic Activation.

Authors:  Róisín M McManus; Orla M Finucane; Mieszko M Wilk; Kingston H G Mills; Marina A Lynch
Journal:  J Neuroimmune Pharmacol       Date:  2017-06-15       Impact factor: 4.147

5.  The Granuloma Response Controlling Cryptococcosis in Mice Depends on the Sphingosine Kinase 1-Sphingosine 1-Phosphate Pathway.

Authors:  Amir M Farnoud; Arielle M Bryan; Talar Kechichian; Chiara Luberto; Maurizio Del Poeta
Journal:  Infect Immun       Date:  2015-04-20       Impact factor: 3.441

6.  Analysis of sphingolipids, sterols, and phospholipids in human pathogenic Cryptococcus strains.

Authors:  Ashutosh Singh; Andrew MacKenzie; Geoffrey Girnun; Maurizio Del Poeta
Journal:  J Lipid Res       Date:  2017-08-15       Impact factor: 5.922

Review 7.  Sphingosine-1-phosphate receptors and innate immunity.

Authors:  Arielle M Bryan; Maurizio Del Poeta
Journal:  Cell Microbiol       Date:  2018-03-23       Impact factor: 3.715

8.  Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility.

Authors:  Lillian Cruz-Orengo; Brian P Daniels; Denise Dorsey; Sarah Alison Basak; José G Grajales-Reyes; Erin E McCandless; Laura Piccio; Robert E Schmidt; Anne H Cross; Seth D Crosby; Robyn S Klein
Journal:  J Clin Invest       Date:  2014-05-08       Impact factor: 14.808

Review 9.  Sphingolipids as targets for treatment of fungal infections.

Authors:  Rodrigo Rollin-Pinheiro; Ashutosh Singh; Eliana Barreto-Bergter; Maurizio Del Poeta
Journal:  Future Med Chem       Date:  2016-08-09       Impact factor: 3.808

Review 10.  Sphingosine-1-phosphate receptor 2.

Authors:  Mohamad Adada; Daniel Canals; Yusuf A Hannun; Lina M Obeid
Journal:  FEBS J       Date:  2013-08-19       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.